Metabolomic analysis has proven to be a useful tool in biomarker discovery and the
molecular classification of cancers. In order to find new biomarkers, and to better understand …

Context The recent discovery of the existence of a human genitourinary microbiome has led
to the investigation of its role in mediating the pathogenesis of genitourinary malignancies …

Simple Summary Bladder cancer (BC) is the fourth most common cancer among men and
the tenth most common cancer among women. Since the overall prognosis for BC has not …

Metabolomics is a dynamic tool for elucidating biochemical changes in human health and
disease. Metabolic profiles provide a close insight into physiological states and are highly …

Bladder cancer (BC) is ones of the most common cancer worldwide. It is classified in muscle
invasive (MIBC) and muscle non-invasive (NMIBC) BC. NMIBCs frequently recur and …

Bladder Cancer (BC) represents a clinical and social challenge due to its high incidence
and recurrence rates, as well as the limited advances in effective disease management …

Bladder cancer (BC) is one of the most frequently diagnosed types of urinary cancer.
Despite advances in treatment methods, no specific biomarkers are currently in use …

The types of urothelial carcinoma (UC) include urothelial bladder cancer and upper tract
urothelial carcinoma. Current diagnostic techniques cannot meet the needs of patients …

Bladder cancer (BC) is frequent cancer affecting the urinary tract and is one of the most
prevalent malignancies worldwide. No biomarkers that can be used for effective monitoring …

Background Traditional intravesical instillation treatment in bladder cancer has limited
efficacy, which results in a high frequency of recurrence. Purpose The aim of this study was …